冠状动脉微血管功能障碍对心力衰竭与保存的喷射分数的影响:一个元分析
Domenico D'Amario1,2, Renzo Laborante3, Emiliano Bianchini3
1Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
ESC heart failure
|March 29, 2024
概括
冠状动脉微血管功能障碍 (CMD) 影响了超过一半的心力衰竭患者,其中有保存的喷射分数 (HFpEF) 患者. 冠状动脉疾病与更糟糕的心声回声检查结果,心房动和死亡或HF住院风险的加倍风险有关.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 内部医学 内部医学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭具有复杂的病因发生.
- 冠状动脉微血管功能障碍 (CMD) 是HFpEF的一个潜在的关键病理生理机制.
- 了解CMD的作用对于改善HFpEF患者的治疗结果至关重要.
结论:
- 冠状动脉疾病是超过一半的HFpEF患者普遍存在的疾病.
- 冠状动脉疾病与更严重的扩张性功能障碍和更高的AF患病率有关.
- 慢性肺炎显著增加了不良临床结果的风险,包括死亡和HF住院治疗.
更多相关视频
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.4K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Pathophysiology of Cardiac Performance
645
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
645
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
